Georg Ingram


Georg Ingram is a highly experienced executive with a track record of 21 years in various top level management positions in the generic pharmaceutical industry. He brings solid expertise in business development, portfolio management and –analysis (also regarding mergers and acquistions), in- and out licensing, project management and general strategic management. Throughout his career, Georg was working in global positions which results in deep knowledge of products, markets and players in Europe, the US and Canada, Asia/Pacific, the Middle East and Latin America.



Georg has founded recently a private consulting firm, gi pharma consulting gmbh, in which he is active as Managing Director. He has worked in highly reputable companies like Sandoz, Pharmascience and Actavis being responsible for global business development and portfolio management.
Before starting his own consultancy, Georg served as EVP Global Business Development for Alvogen. In this function, he closed over 200 license- and strategic BD deals within six years which helped to grow alvogen to one of the most dynamic players in the generic industry with a turnover of over USD 750 million these days.


Georg holds a Master of Science and a Ph.D. in Chemistry from the University of Innsbruck, Austria. Furthermore he participated in various trainings like the Harvard Business Finance Program and the Novartis Leadership Program.